HSF1 and neoplasm: In breast cancer, since the activation of AKT and the subsequent activation of HSF1 by p-AKT shortens the metastatic intervals of tumor cells, inhibition of the AKT/HSF1 signaling axis resulted in the reduced number of metastatic breast cancer cells and cancer stem cells [80].